Inventor · disambiguated record
Min Zhu
Also filed as: ZHU MIN
8 granted patents·33 pending applications·592 citations·filing 2000–2024
85Inventor score
Files withKATZ ADAM J8SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD6MEDIMMUNE LLC3REGENERON PHARMA3UNIV CALIFORNIA3
Top patents by PatentIndex Score
41 records- 0196US7470537B2Adipose-derived stem cells and latticesUNIV CALIFORNIA·Filed 2003·Granted Dec 30, 2008·98 cites·3 claims
- 0296US6777231B1Adipose-derived stem cells and latticesUNIV CALIFORNIA·Filed 2000·Granted Aug 17, 2004·484 cites·10 claims
- 0388US9597395B2Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditionsFRASER JOHN K·Filed 2005·Granted Mar 21, 2017·10 cites·61 claims
- 0469US2009269315A1Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditionsFRASER JOHN K·Filed 2009·Application pending·0 cites
- 0568US2024327457A1Lipopeptides, nanoparticles and methods of useWISCONSIN ALUMNI RES FOUND·Filed 2024·Application pending·0 cites
- 0667US2010173411A1Adipose-derived stem cells and latticesKATZ ADAM J·Filed 2009·Application pending·0 cites
- 0764US2015376572A1Adipose-derived stem cells and latticesKATZ ADAM J·Filed 2014·Application pending·0 cites
- 0864US2004171146A1Adipose-derived stem cells and latticesUNIV PITTSBURGH·Filed 2004·Application pending·0 cites
- 0963US2009181456A1Adipose-derived stem cells and latticesHEDRICK MARC H·Filed 2008·Application pending·0 cites
- 1061US2005076396A1Adipose-derived stem cells and latticesFiled 2003·Application pending·0 cites
- 1160US12466874B2Prevention of protein disulfide bond reductionMEDIMMUNE LLC·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 1260US2013224858A1Adipose-derived stem cells and latticesKATZ ADAM J·Filed 2013·Application pending·0 cites
- 1360US2023277483A1Compositions and methods to treat inflammationUNIV IOWA RES FOUND·Filed 2023·Application pending·0 cites
- 1460US2025154135A1M-choline receptor agonist compound, preparation method therefor and use thereofNANJING GRITPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1560US2023182041A1Purification of antibodiesMEDIMMUNE LLC·Filed 2022·Application pending·0 cites
- 1659US2013217118A1Adipose-derived stem cells and latticesKATZ ADAM J·Filed 2012·Application pending·0 cites
- 1757US2015191698A1Adipose-derived stem cells and latticesKATZ ADAM J·Filed 2015·Application pending·0 cites
- 1857US2012208274A1Adipose-derived stem cells and latticesKATZ ADAM J·Filed 2012·Application pending·0 cites
- 1956US2023374160A1Combination of antibodies for treating cancer with reduced cytokine release syndromeREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 2056US2011318833A1Adipose-derived stem cells and laticcesKATZ ADAM J·Filed 2011·Application pending·0 cites
- 2155US2024399341A1Ethylbenzene dehydrogenation catalyst, preparation method therefor, and use thereofCHINA PETROLEUM & CHEM CORP·Filed 2022·Application pending·0 cites
- 2255US2023272118A1Dosing Regimens for Mitigation of Cytokine Release SyndromeREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2355US2024190937A1Human insulin c-alpha-peptides and methods of useUS HEALTH·Filed 2022·Application pending·0 cites
- 2455US2017281771A1Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditionsCYTORI THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2554US11427635B2CD47 single-domain antibody and use thereofSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted Aug 30, 2022·0 cites·16 claims
- 2654US2023312718A1Methods of Treating Recurrent Ovarian Cancer with Bispecific Anti-MUC16 x Anti-CD3 Antibodies Alone or in Combination with Anti-PD-1 AntibodiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2753US2003082152A1Adipose-derived stem cells and latticesFiled 2001·Application pending·0 cites
- 2853US2023381751A1Iron-potassium-cerium-based composite oxide catalyst, and preparation and application thereofCHINA PETROLEUM & CHEM CORP·Filed 2021·Application pending·0 cites
- 2952US12012456B2Anti-interleukin-4 receptor (IL-4R) single-domain antibody, encoding polynucleotide and methods of making and using the antibody for IL-4R detection and disease treatmentSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Jun 18, 2024·0 cites·21 claims
- 3052US2011027879A1Adipose-derived stem cells and latticesKATZ ADAM J·Filed 2010·Application pending·0 cites
- 3151US2005008626A1Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditionsFiled 2004·Application pending·0 cites
- 3250US2005153442A1Adipose-derived stem cells and latticesFiled 2004·Application pending·0 cites
- 3349US2005282275A1Adipose-derived stem cells and latticesUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 3449US2024368264A1Anti-TSLP nanobodies and their applicationsSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 3547US11912770B2Blocking type PD-L1 single-domain camel antibody and application thereofSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Feb 27, 2024·0 cites·15 claims
- 3647US2023399395A1Anti-il5 nanoantibody and use thereofSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3745US12477214B2Methods and apparatuses for assisted pet image capturingANT SHENGXIN SHANGHAI INFORMATION TECH CO LTD·Filed 2023·Granted Nov 18, 2025·0 cites·20 claims
- 3845US2002076400A1Adipose-derived stem cells and latticesUNIV PITTSBURGH·Filed 2001·Application pending·0 cites
- 3944US2019112357A1Prevention of protein disulfide bond reductionMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 4042US2016177250A1Tissue transfer systemCYTORI THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4139US2022324954A1Anti-vegf single-domain antibody and use thereofSHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Min Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →